HEART CHANGES IN COVID-19 INFECTION

Abstract

A new pathogen spread in Wuhan, China in December 2019, causing symptoms similar to pneumonia, and was later identified as SARS-CoV-2, which causes COVID-19 disease. Soon after, the World Health Organization (WHO) declared it as a high-risk international emergency disease, a pandemic. Among the various complications caused by COVID-19, cardiac complications are rarely mentioned, however they represent a great risk to those infected, with emphasis on elderly individuals and with cardiac comorbidities. Thus, the study on the consequences of COVID-19 on cardiac complications, with an emphasis on alterations in laboratory tests, can assist in the diagnosis and treatment of cardiovascular injuries caused by SARS-CoV-2, improving the patient's prognosis. Articles available in the online literature were used as a basis for the construction of the article, with data being observed, the literature reports that at least 8% of patients diagnosed with COVID-19 developed an acute cardiac injury, increasing the risk of death twice. Through the use of biomarkers such as ultra-sensitive troponin and D-dimer, which are elevated in COVID-19 patients with cardiovascular injury, an early diagnosis of the development of injuries can be obtained, increasing the chances of survival and improving the patient's prognosis.